Connect with us

Cannabis News

Kentucky Governor Slams GOP Lawmaker For ‘Lack Of Humanity’ Over Push For Medical Marijuana Prosecutions

Published

4 months ago

on

Kentucky’s Democratic governor is calling a top GOP lawmaker a “total lack of humanity” after he suggested state law enforcement officials should prosecute people who act under a recent executive order to expand access to medical cannabis.

Gov. Andy Beshear (D) signed the order last week expanding the list of health conditions for which patients are legally eligible to obtain medical cannabis.

Days later, House Majority Whip Jason Nemes (R) asked Attorney General Russell Coleman (R). ensure that state agencies are “not cooperating” with the governor’s marijuana directiveWhich he called “illegal”.

“Any organization, any licensee involved in this illegal expansion should be prosecuted,” Nemes said at a legislative committee hearing. “This is not the way forward.”

On Thursday, Beshear said signing the cannabis order “was the right thing to do, and it was necessary, because they write in the name of certain medical conditions in the law, but then they write in symptoms like pain and nausea, which are all clearly symptoms.”

After the Legislature declined to take up a proposal this session to expand the list of conditions, Beshear used his authority to also ensure that patients with 15 additional health disorders (Parkinson’s disease, HIV/AIDS, sickle cell anemia, fibromyalgia, arthritis and glaucoma) also have access to medical marijuana.

“A lot of people are helping, and I was really surprised to see an attack from a lawmaker who called on the attorney general to prosecute people who were dying of a terminal illness to ensure medical cannabis,” the governor said Thursday. “I mean, that’s a complete lack of humanity. It’s really low. I mean, you want to judge a person with ALS? That’s definitely not leadership, and even for that person, it’s a new record.”

“Sometimes we see people making those threats, and in today’s culture, I think they think it’s masculinity, but masculinity is not being the bully on the playground. It’s being the person who stands between the bully and the person who’s picking on them. That’s my job, to stand between those bullies and those people with these very serious conditions, to say, ‘something that makes me addicted,’ what makes me addicted. Opioids, and that can help.” That’s what I’m going to do as governor. These people are in real pain, they need help. they have and they need this safe alternative. Politics should never get in the way of doing what’s right for Kentucky.”

Beshear announced Thursday that he rescinded an earlier executive order issued in 2022 that offered. apologize to patients who have been in trouble for possessing medical cannabis that they bought it from a legal dispensary in a neighboring state.

Kentucky’s medical marijuana program has progressed to the point where cannabis is now “readily available” to patients who need it, the governor said, so the amnesty order will expire on July 1.

“This should give people plenty of time, the rest of the month, if you’re traveling out of state, to contact an eligible doctor and apply for a medical cannabis card right here in Kentucky,” he said.




The latest executive order on the terms is a follow-up to Beshear’s 2023 bill to legalize medical cannabis.

At a press conference last week to announce the new medical marijuana order, the governor also said he believes “it’s time” for broader decriminalization of cannabis.

He also cited the results of a recent study by researchers at the University of Kentucky making regulated medical marijuana dispensaries available to lower opioid overdose rates.

Meanwhile, in addition to asking the Legislature to continue the process of expanding the list of conditions for medical marijuana, Beshear also announced in February Cannabis gummies can be purchased at state-licensed dispensaries.

The governor of January also said “not happy” with the time it’s taken to roll out the state’s medical marijuana program—but predicts that the pace of patient access will “significantly increase” in 2026.

The The state’s first medical cannabis dispensary opened in December last year

The governor, who has long championed cannabis reform, he anticipated a market launch that monthwhile claiming that medical marijuana will help thousands of patients find an alternative to opioids for pain management.

He at the end of October it passed the milestone of registering 15,000 patientsbut that has grown significantly in recent months.

Beshear previously acknowledged that “it’s taken longer than we would have liked” to sustain the industry since he signed off on legalizing medical marijuana in 2023.

Considering this delayed implementation, he He signed an executive order to waive renewal fees for patients who get the cards so that they are not charged again before the stores open. And another order he signed to provide protections for qualified patients who obtain medical marijuana outside of Kentucky “will remain in place.”

Beshear announced separately last year that the state had launched a new online directory that allows people to see where medicinal cannabis will open next to them

He noted that the state is working to provide access to patients “as soon as possible,” which includes speeding up the licensing process. Last year, so did the governor ceremoniously issued the first medical marijuana cards in the commonwealth.

Meanwhile, the governors sent a letter to Kentucky’s congressional delegation last yearurging them to “take decisive action to protect the constitutional rights of our law-abiding medical cannabis patients” by repealing the federal ban on possession of firearms by marijuana users.

Bipartisan Kentucky senators introduced similar legislation asked the federal representatives of the state to take corrective measuresBeshear said he agrees but would I would like to see even more significant changes at the federal level.

The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents that in 2024, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law.

In the November 2024 election, Kentucky also saw more than 100 cities and counties pass local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results show that “the jury is no longer out” on the issue this is clearly supported by voters across party and geographic lines.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Fluent to sell New York license and operations

Published

2 months ago

on

July 30, 2026

By











Fluent has entered into a definitive agreement to sell Etain, LLC, the Company’s New York-based operating entity. The purchase agreement was signed on July 22, 2026. The transaction provides for the sale of Etain’s Registered Entity license, certain of the Company’s New York operating assets and related New York leases for cash, subject to customary purchase price adjustments.

The Company believes the Transaction advances its strategic objectives and expects the Transaction to comply with applicable regulatory requirements in connection with the Company’s previously announced plan of arrangement for Vireo Growth Inc. (the “Deal”) while providing for an orderly transition of the New York operations to an experienced operator committed to serving patients and consumers.

Completion of the free transaction is subject to closing conditions, including, among other customary conditions, approval of the change in ownership by the New York State Cannabis Control Board and the completion of all conditions to the completion of the Agreement.

For more information:
FLUENT Corp
getfluent.com/










Continue Reading

Cannabis News

Marijuana Has ‘Horrific Health Risks’ And No Medical Value, Former Trump Attorney General Claims

Published

2 months ago

on

July 30, 2026

By

A former US attorney general who served in President Donald Trump’s first term says marijuana poses “tremendous health risks,” has no medical value and should not be rescheduled under federal law.

“Marijuana redistricting would create a false impression that it is safe, reduce penalties for illegally selling the drug, and provide a large tax windfall to those who legally supply it,” William Barr wrote in a Wednesday op-ed for The Washington Post, Kevin Sabet, CEO of the prohibitionist organization Smart Approaches to Marijuana. “That would be a disaster.”

The opinion comes as the Trump administration moves forward with cannabis reregulation.

According to an order issued in April by US Attorney General Todd Blanche, Marijuana products regulated by a state medical cannabis license were immediately changed from Schedule I As did marijuana products approved by the Food and Drug Administration (FDA) under Schedule III of the Controlled Substances Act (CSA).

an administrator The hearing is looking at the broader rescheduling of marijuanawith The Drug Enforcement Administration (DEA) has been tasked with advocating for cannabis reform highlighting the testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids. It included appearances by a Food and Drug Administration (FDA) scientist and a doctor from New Hampshire. Medical marijuana provides relief to pain patients and can serve as an alternative to opioids.

But Sabet and Barr, who served as Trump’s attorney general from 2019-2020, argued that “the evidence presented at the hearing did not support the rescheduling of marijuana” and instead “confirmed what decades of data have shown: raw marijuana has no scientifically established medical value and is highly susceptible to abuse.”

After the parties to the hearing have filed termination rights, the DEA administrative law judge overseeing the proceedings will make a recommendation regarding rescheduling, and the agency administrator will make a final decision.

DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling supporters that they do not meet the definition of “interested person” to participate because they have not been “affected or prejudiced by any rule or proposed rule that may be issued.”

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The former attorney general’s new opinion says “the stakes couldn’t be higher”, arguing that “marijuana today is more dangerous than ever” and that it is “addictive”, throwing out a list of alleged harm to mental and physical health.

“These unhealthy effects are a predictable result of a powerful and addictive drug being normalized, commercialized and marketed as a medicine,” Barr and Sabet say. “It would be one thing if marijuana had medical value. But there is no credible evidence that marijuana is an effective treatment for any medical condition, despite the millions of dollars spent trying to prove otherwise.”

The Department of Health and Human Services (HHS) published a 252 analysis in 2023 that concluded that marijuana had accepted medical value and should be rescheduled.

The new opposition piece also says that “rescheduling would unlock enormous revenue for the corporate marijuana industry by bringing it into a category that has not been covered by a longstanding reduction in federal drug tax deductions,” referring to a law known as 280E, which repeals Sections I and II.

“This, in turn, would allow the industry to spend even more on advertising and marketing to young people,” Barr and Sabet. he wroteArguing that “those who would lose this dragon in society are laying the foundations for another Big Tobacco”.

The Sabet organization, SAM, is one of several parties Challenging the Marijuana Redistricting Process which have been upheld by a federal Court of Appeals. those separate parts State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

SAM’s lawsuit was signed by attorneys at Torridon Law PLLC, where Barr is a partner.

The team announced in January that it was Hiring Barr’s firm to fight cannabis rescheduling After Trump signed an executive order directing officials to quickly complete the process.

During the first Trump administration, Barr was accused by a Justice Department official Directing improper anti-company investigations into multiple cannabis company mergers– Accounting for almost a third of the division’s cases in 2019.

Several Democratic members of Congress introduced a resolution calling for an investigation into Barr’s possible impeachment, saying “abused the power of his office” to improperly investigate marijuana businesses while engaging in other allegedly illegal conduct.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

How much red light does cannabis really need?

Published

2 months ago

on

July 26, 2026

By

When growers pull out two LED fixtures side by side, the first number they usually discuss is percent red. This is an easy specification to fix. They are efficient at producing red photons and incredibly efficient at photosynthesis, and cannabis eats away at the flower. So more red must be better, right?

Not so simple. Red is an input to a spectrum, and the spectrum is an input to a room. There is no single spectrum that wins everywhere. An indoor room pushes hard, a greenhouse that soaks up sunlight, a temperamental cultivar, and aggressive yields call for something different. Knowing what each light strip actually does allows you to choose a tool that fits your grow instead of one that just has a big number on the sales page.

© JumpLights

Blue: structure
Blue (approximately 400-500 nm) gives shape to the plant. It maintains dense growth, strong stems, tight internodes and allows it to develop as desired. It also encourages stomatal opening, so the plant manages water and gas exchange better. Get blue and you’ve built a plant that can carry heavy flowers with no problem.

Green: access
Green was eliminated as the wavelength is “reflected” by plants. It turns out that it does a real job. Blue and red are absorbed above; the green goes deep into the fat and reaches the leaves that are never touched by the above photons. In a compact room, it’s the difference between plants photosynthesising from the top down and those that work only from the top. Green won’t replace your red or blue, but it does carry usable light where they can’t reach.

Red: engine
Red is the horse of the flower. It absorbs as efficiently as anything in the spectrum, and is responsible for most of the biomass you’re after. Redder generally means faster flower development, more weight and better efficiency per watt.

But red has a ceiling, and it’s tied to what you run. Push PPFD upwards with a heavy red spectrum and some cultivars begin to whiten at the top: the flower should be dense with pale, washed tips. Genetics, intensity, barrel temperature and your general environment all feed into it. If you’re using aggressive light levels, a lower red spectrum will buy you room before that becomes a problem, leaving you almost no photosynthetic punch to get it.

Far Red: More than Emerson
Far-red (700-750 nm) appears in more devices every year. It contributes little to photosynthesis on its own, but it moves plant morphology and works with red through the Emerson Enhancement Effect. Used properly, it helps to deepen the light, encourage uniformity of the canopy and encourage the response of the bloom. The key word is small. A touch of far red rounds out a spectrum; he’s not there to make a show.

Matching the red percentage with the room
Cannabis addresses the entire spectrum, not a line on a spec sheet. Reds cause flowers, but blues, greens and crimsons give the plant something it needs. Where you land in red refers to how you grow.

A lower red spectrum (30-40%) captures more blue and green, gives you better morphology, reduces the risk of photobleaching, and holds up when you’re running extreme PPFD. Moderate spectrum (40-55%) is the sweet spot in commercial greenhouses: strong photosynthetic efficiency, strong flowering, balanced growth. A high-red spectrum (70%+) makes the most sense in a greenhouse, where the sun is already giving you lots of blue and green and your supplemental light can cast effective red to fill the gap.

Where does the ETS MAX series fit in?
This is the thinking behind the JumpLights ETS MAX series. Instead of forcing a spectrum into each room, it rarely comes up because a greenhouse and a high PPFD indoor flower room are not the same problem.

  • ETS MAX 4C41% red: for indoor rooms operating at very high intensity, where photobleaching is a real risk. The wider, red bottom balance allows you to push the tops without overcooking them
  • ETS MAX 4A48% red: balanced internal spectrum that maintains high output while controlling bleaching.
  • ETS MAX 5B57% Red: A high-performance indoor option. Moderate red, marked with efficiency and flower at the same time, up to 3,450 μmol/s, with efficiency that holds the spectrum.
  • ETS MAX 7A76% red: built for the greenhouse. The sun already supplies blue and green, so this leans heavily on the complementary red, up to 3,900 μmol/s in the infrastructure most greenhouses already have in place.

Bottom line
Choosing an activity is not a competition for the highest red number. The winning spectrum is the one that matches your environment, your intensity, your genetics, and what you’re trying to produce. Combine spectrum, intensity, environmental control, light distribution and genetics, and you’ve got a lighting strategy. Keep a spec isolated and all you’ve got is a bright room.

The ETS MAX line was created around this idea: choose the spectrum of the room you actually have, indoor or greenhouse, and let the device work with your grow rather than against it.

For more information:
JumpLights
www.jumplights.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media